Isomorphic Labs, a Google DeepMind spinoff, is set to see its AI-designed drugs enter clinical trials this year, according to Nobel Prize-winning CEO Demis Hassabis.“We’ll...
AlphaFold
Artificial Inteligence
clinical trials
drug discovery
Isomorphic Labs
protein prediction
Technology